pharmacie et médicaments – Baisse des remises applicables aux médicaments génériques

This written question concerns the rebates applied to generic medicines in France. It seeks clarification on the current financial mechanisms affecting the pricing and accessibility of these essential drugs. The question impacts pharmaceutical companies, healthcare providers, and ultimately patients who rely on affordable generic medications for their treatment.